Delivery Order SPE2DB22D3004-SPE2DB24FNH55
- Not listed
- This federal contract award, valued at $8,372.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HIBICLENS 4% LIQUID 946ML, a medical product, and has an ultimate completion date of July 10, 2024. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
- This federal contract award is a Delivery Order valued at $5,426.90 with an ultimate completion date of June 7, 2024. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of HIBICLENS 4% LIQUID 946ML, a medical product, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB23FL24R, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,645.33 firm-fixed-price delivery order is for the supply of 4% Hibiclens liquid in 946 ml bottles. This contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,642.19 firm fixed-price delivery order is for the supply of Hibiclens 4% Liquid antiseptic hand wash, with a period of performance through September 5, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,209.15 for HIBICLENS 4% Liquid (946ml) on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HIBICLENS is an antimicrobial skin cleanser commonly used in healthcare settings for preoperative skin...
- The Defense Logistics Agency awarded a $285,160 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 473ml bottles of 4% Hibiclens with foam pumps. As part of its medical supply chain responsibilities for the Department of Defense, DLA issued the order under an existing Prime Vendor contract vehicle to provide antiseptic skin cleanser bottles for use across military treatment facilities. Amerisourcebergen will fulfill the order from its Conshohocken, Pennsylvania...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,959.10 for the supply of 4566188099 - Chlorhexidine 0.12% 15 ML CUP UD 15ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of October 24, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. Amerisourcebergen has an Indefinite Delivery Contract (IDC)...
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $12,268.15 firm fixed-price delivery order is for the supply of 473-milliliter bottles of 0.12% chlorhexidine rinse. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Chlorhexidine 0.12% Rinse 473ML. The $1,171.76 Firm Fixed Price contract has an ultimate completion date of July 19, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,841.28 Firm Fixed Price Delivery Order is for the supply of Chlorhexidine 0.12% Rinse, a medical product used for oral care. The contract has a completion date of July 30, 2024 and does not utilize any set-aside designation. Amerisourcebergen, through its extensive supply chain capabilities, will provide this critical medical supply to...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FNH55Delivery Order
This federal contract award, with the ID SPE2DB22D3004|SPE2DB24FNH55, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the supply of HIBICLENS 4% LIQUID 118ML, a medical product, with a ceiling value of $4,626.72 and a completion date of November 2, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 11/1/23 |